Euro
USD
British Pound
NULL
Product Description
GS-441524 (Remdesivir Metabolite) | 10-038 | ProSci
BNR: Chemical
Predicted Molecular Weight: 291, 3
Physical State: Lyophilized
Storage Condition: Short Term Storage: +4C. Long Term Storage: -20C. Handling Advice: Keep cool and dry. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.
Alternate Name: N/A
Background: GS-441524 is the active prodrug of the broad-spectrum antiviral Remdesivir. GS-441524 is an adenosine nucleotide analog in viral RNA production. It is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps) . The compound interferes with the action of viral RNA polymerase and evades proofreading by viral exoribonuclease (ExoN), causing a decrease in viral RNA production (RNA synthesis arrest), either by terminating RNA chains or causing mutations. It inhibits MERS-CoV or SARS-CoV-infected HAE cultures (EC50=74nM and 69nM) and murine hepatitis virus (MHV) (EC50=30nM) . In vivo, remdesivir (Prod. No. AG-CR1-3713) (25 and 50 mg/kg) reduces lung viral titers and prevents weight loss in a mouse model of SARS-CoV infection. Remdesivir (Prod. No. AG-CR1-3713) is used as a treatment for Ebola virus disease and Marburg virus infections and other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus and the coronaviruses (including MERS and SARS viruses) . Remdesivir is effective in the control of 2019-nCoV (COVID-19) infection in vitro. It now also has been studied as potential treatment of SARS-CoV-2 infections
Disclaimer: This product is for research use only.
Purity: greater than or equal to 98% (HPLC)
Formula: C12H13N5O4
Source: N/A
Solubility: Soluble in DMSO (15mg/ml) or DMF (15mg/ml) .
InChi Key: BRDWIEOJOWJCLU-LTGWCKQJSA-N
Smiles: NC1=NC=NN2C1=CC=C2[C@]3 ([C@@H] ([C@@H] ([C@H] (O3) CO) O) O) C#N
RTECS: N/A
Identity: Determined by 1H-NMR.
Merck Index: N/A
